Medical management of chronic rhinosinusitis

Immunology and Allergy Clinics of North America

Volumn 24, Issue 1, 2004, Pages 103-118

  Scadding, Glenis K ^a  

^a ROYAL NATIONAL THROAT NOSE AND EAR HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; ANTIINFLAMMATORY AGENT; ANTIVIRUS AGENT; AZITHROMYCIN; BACTERIAL VACCINE; CLARITHROMYCIN; CORTICOSTEROID; FUROSEMIDE; LYSINE ACETYLSALICYLATE; MACROLIDE; NITRIC OXIDE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; ROXITHROMYCIN; TOBRAMYCIN; VANCOMYCIN;

ALLERGIC RHINITIS; CHRONIC SINUSITIS; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; FACE PAIN; FEVER; GASTROINTESTINAL DISEASE; HALITOSIS; HEADACHE; HUMAN; INFECTION; MYCOSIS; NONHUMAN; NOSE CONGESTION; PATIENT CARE; PRIORITY JOURNAL; QUALITY OF LIFE; RECURRENT DISEASE; REVIEW; RHINOSINUSITIS; VASCULITIS;

EID: 1142309638     PISSN: 08898561     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-8561(03)00110-3     Document Type: Review

References (85)

1. Lund V.J., Kennedy D.W. Staging for rhinosinusitis. Otolaryngol Head Neck Surg. 117:1997;35-40.
2. Otten F.W., Van Aarem A., Grote J.J. Long term follow up of chronic therapy resistant purulent rhinitis in children. Clin Otolaryngol. 17:1992;32-33.
3. Clement P.A., Bijloos J., Kaufman L., Lauwers L., Maes J.J., Van der Veken P.et al. Incidence and etiology of rhinosinusitis in children. Acta Otorhinolaryngol Belg. 43:1989;523-543.
4. Manning S.C., Biavati M.J., Phillips D.L. Correlation of clinical sinusitis signs and symptoms to imaging findings in pediatric patients. Int J Pediatr Otorhinolaryngol. 37:1996;65-74.
5. Lloyd G.A.S., Lund V.J., Scadding G.K. CT of the paranasal sinuses and functional endoscopic surgery - a critical analysis of 100 symptomatic patients. J Laryngol Otol. 105:1999;181-185.
6. Bachert C., Van Cauwenberge P.B. Inflammatory mechanisms in chronic sinusitis. Acta Otorhinolaryngol Belg. 51:1997;209-217.
7. Raman V., Clary R., Siegrist K.L., Zehnbauer B., Chatila T.A. Increased prevalence of mutations in the cystic fibrosis transmembrane conductance regulator in children with chronic rhinosinusitis. Pediatrics. 109:2001;E13.
8. Ragab S. Medical versus surgical management of chronic rhinosinusitis [MD thesis]. 2002;University College, London.
9. Taccariello M., Parikh P., Darby Y., Scadding G.K. Nasal douching in chronic rhinosinusitis: a randomised, single-blind study comparing alkaline nasal douche and sterile sea water. Rhinology. 37:1999;29-32.
10. Tomooka L.T., Murphy C., Davidson T.M. Clinical study and literature review of nasal irrigation. Laryngoscope. 110:2000;1189-1193.
11. Golusinski W., Szmeja Z., Szyfter W., Kruk-Zagajewsk A., Mielcarak-Kutchta D., Lackowska-Przybiska J. The use of mucolytic (mucosalvan) in nasal and paranasal sinuses in children. Otolaryngol Pol. 50:1996;599-606.
12. Marz R.W., Ismail C., Popp M.A. Wirkprofil und Wirksamkeit eines pflanzlichen Kombinationspraparates zur Behandlung der Sinusitis. Wien Med Wochenschr. 149:1999;202-208. in German.
13. Wiener J.M., Abramson M.J., Puy R.M. Intranasal corticosteroids versus oral H1 receptor antagonists in allergic rhinitis: systematic review of randomized controlled trials. BMJ. 317:1998;1624-1629.
14. Meltzer E.O., Orgel H.A., Backhaus J.W., Busse W.W., Druce H.M., Metzger W.J.et al. Intranasal flunisolide spray as an adjunct to oral antibiotic therapy for sinusitis. J Allergy Clin Immunol. 92:1993;812-823.
15. Dolor R.J., Witsell D.L., Hellkamp A.S., Williams J.W. Jr., Califf R.M., Simel D.L.et al. Comparison of cefuroxime with or without intranasal fluticasone for the treatment of rhinosinusitis: the CAFFS Trial: a randomised controlled trial. JAMA. 286:2001;3097-3105.
16. Meltzer E.O., Charous B.L., Busse W.W., Zinreich S.J., Lorber R.R., Danzig M.R. Added relief in the treatment of acute recurrent sinusitis with adjunctive mometasone furoate nasal spray: the Nasonex Sinusitis Group. J Allergy Clin Immunol. 106:2000;630-637.
17. Cuenant G., Stipon J.P., Plante-Longchamp G., Baudoin C., Guerrier Y. Efficacy of endonasal neomycin-toxocortol pivalate irrigation in the treatment of chronic allergic and bacterial sinusitis. ORL J Otorhinolaryngol Relat Spec. 48:1986;226-232.
18. Qvarnberg Y., Kantola O., Salo J., Toivanen H., Vuori E. Influence of topical steroid treatment on maxillary sinusitis. Rhinology. 30:1992;103-112.
19. Parikh A., Scadding G.K., Darby Y.C., Baker R.C. Topical corticosteroids in chronic rhinosinusitis: a randomized, double blind, placebo controlled trial using fluticasone propionate aqueous nasal spray. Rhinology. 39:2001;75-79.
20. Lund V., Black S., Laszlo Z.S., Schwerelius C. Budesonide aqueous nasal spray (BANS, Rhinocort aqua) is effective as monotherapy in stable patients with chronic rhinosinusitis. J Allergy Clin Immunol. 109:2002;S290.
21. Lildholdt T., Runderantz H., Bende M., Larsen K. Glucocorticoid treatment for nasal polyps: the use of topical budesonide powder, intramuscular betamethasone and surgical treatment. Arch Otolaryngol Head Neck Surg. 123:1997;595-600.
22. Rasp G., Kramer M.F., Ostertag P., Kastenbauer E. A new system for the classification of ethmoid polyposis: effect of combined local and systemic steroid therapy. Laryngorhinootologie. 79:2000;266-272.
23. Van Camp C., Clement P.A. Results of oral steroid treatment in nasal polyposis. Rhinology. 32:1994;5-9.
24. Holopanien E., Grahne B., Malmberg H., Makinein J., Lindqvist N. Budesonide in the treatment of nasal polyposis. Eur J Respir Dis Suppl. 122:1982;221-228.
25. Drettner B., Ebbesen A., Nilsson M. Prophylactic treatment with flunisolide after polypectomy. Rhinology. 20:1982;149-158.
26. Dingsor G., Kramer J., Olsholt R., Soderstrom T. Flunisolide nasal spray 0.025% in the prophylactic treatment of nasal polyposis after polypectomy: a randomized, double blind, parallel, placebo controlled study. Rhinology. 23:1985;49-58.
27. Holmberg K., Juliusson S., Balder B., Smith D.L., Richards D.H., Karlsson G. Fluticasone propionate aqueous nasal spray in the treatment of nasal polyposis. Ann Allergy Asthma Immunol. 78:1997;270-276.
28. Hartwig S., Linden M., Laurent C., Vargo A.K., Lindqvist N. Budesonide nasal spray as prophylactic treatment after polypectomy (a double blind clinical trial). J Laryngol Otol. 102:1988;148-151.
29. Ruhno J., Andersson B., Denburg J., Anderson M., Hitch D., Lapp P.et al. A double-blind comparison of intranasal budesonide with placebo for nasal polyposis. J Allergy Clin Immunol. 86:1990;946-953.
30. Chalton R., Mackay I., Wilson R., Cole P. Double-blind, placebo-controlled trial of betamethasone nasal drops for nasal polyposis. Br Med J (Clin Res Ed). 29:1985;788.
31. Keith P., Nieminen J., Hollingworth K., Kolovich J. Efficacy and tolerability of fluticasone propionate nasal drops 400mgs once daily compared with placebo for the treatment of bilateral polyposis in adults. Clin Exp Allergy. 30:2000;1460-1468.
32. Pentila M., Poulsen P., Hollingworth K., Holmstrom M. Dose-related efficacy and tolerability of fluticasone propionate nasal drops 400 mg once daily and twice daily in the treatment of bilateral nasal polyposis: a placebo-controlled, randomised study in adult patients. Clin Exp Allergy. 30:2000;94-102.
33. Sykes D.A., Wilson R., Chan K.L., Mackay I.S., Cold P.J. Relative importance of antibiotic and improved clearance in topical treatment of chronic mucopurulent rhinosinusitis: a controlled study. Lancet. 2(8503):1986;359-360.
34. Benammer-Englmairer M., Hallertmeier J.K., Englmaier B. Alpha-mimetic effects on nasal mucosa in magnetic resonance tomography. Digitale Bilddiagn. 10:1990;46-50.
35. McCormick D.P., John S.D., Swischuk L.E., Uchinda T. A double-blind, placebo-controlled trial of decongestant antihistamine for the treatment of sinusitis in children. Clin Pediatr (Phila). 35:1996;457-460.
36. Otten F.W., Grote J.J. Otitis media with effusion and chronic upper respiratory tract infection in children: a randomised, placebo-controlled clinical study. Laryngoscope. 100:1990;627.
37. De Ferranti S.D., Ioannidis J.P., Lau J., Anninger W.V., Barza M. Are amoxicillin and folate inhibitors as effective as other antibiotics for acute sinusitis? A meta-analysis. BMJ. 317:1998;632-637.
38. Williams J.W. Jr., Aguilar C., Makela M.et al. Penicillin V or amoxicillin is better than placebo and equal to non-penicillins for acute maxillary sinusitis. Evidence-Based Medicine. 5:2000;43.
39. Poole M.D., Jacobs M.R., Anon J.B., Marchant C.D., Hoberman A., Harrison C.J. Antimicrobial guidelines for the treatment of acute bacterial rhinosinusitis in immunocompetent children. Int J Pediatr Otorhinolaryngol. 63:2002;1-13.
40. Davidson T.M., Murphy C., Mitchell M., Smith C., Light M. Management of chronic sinusitis in cystic fibrosis. Laryngoscope. 105:1995;354-358.
41. Goh Y.H., Goode R.L. Current status of topical nasal antimicrobial agents. Laryngoscope. 110:2000;875-880.
42. Kamijyo A., Matsuzaki Z., Kikushima K.et al. Fosfomycin nebulizer therapy to chronic sinusitis. Auris Nasus Larynx. 28:2001;227-232.
43. Desrosiers M.Y., Salas-Prato M. Treatment of chronic rhinosinusitis refractory to other treatments with topical antibiotic therapy delivered by means of a large particle nebulizer: results of a controlled trial. Otolaryngol Head Neck Surg. 125:2001;265-269.
44. Biel M.A., Brown C.A., Levinson R.M., Gavis G.E., Paisner H.M., Sigel M.E.et al. Evaluation of the microbiology of chronic maxillary sinusitis. Ann Otol Rhinol Laryngol. 107:1998;942-945.
45. Morris P. Antibiotics for persistent nasal discharge (rhinosinusitis) in children. Cochrane Database Syst Rev. 3(CD001094):2000;150-155.
46. Jacobs M.R. Optimization of antimicrobial therapy using pharmacokinetic and pharmacodynamic parameters. Clin Microbiol Infect. 7:2001;589-596.
47. Hickner J.M., Bartlett J.G., Besser R.E., Gonzales R., Hoffman J.R., Sande M.A.et al. Principles of appropriate antibiotic use for acute rhinosinusitis in adults - a background. Ann Intern Med. 134:2001;498-505.
48. Kudoh S., Azuma A., Yamamoto M., Izumi T., Ando M. Improvement of survival in patients with diffuse panbronchiolitis treated with low-dose erythromycin. Am J Respir Crit Care Med. 157(6 Pt 1):1998;1829-1832.
49. Ichimura K., Shimazaki Y., Ishibashi T., Higho R. Effect of new macrolide roxithromycin upon nasal polyps associated with chronic sinusitis. Auris Nasus Larynx. 23:1996;48-56.
50. Suzuki H., Ikeda K., Honma R., Gotoh S., Oshima T., Furukawa M.et al. Antimicrobial treatment and recurrent rhinosinusitis. Arch Otolaryngol Head Neck Surg. 126:2000;690.
51. Prasad A.S., Fitzgerald J.T., Bao B.et al. Duration of symptoms and plasma cytokine levels in patients with the common cold treated with zinc acetate - a randomized, double-blind, placebo-controlled trial. Ann Intern Med. 133:2000;245-251.
52. Puhakka T., Makela M.J., Malmstrom K., Uhari M., Savolainen J., Terho E.O.et al. The common cold: effects of intranasal fluticasone propionate treatment. J Allergy Clin Immunol. 101:1998;726-731.
53. Ruohola A., Heikkinen T., Waris M., Puhakka T., Ruuskanen O. Intranasal fluticasone propionate does not prevent acute otitis media during upper respiratory infection in children. J Allergy Clin Immunol. 106:2000;467-471.
54. Schubert M.S. Medical treatment of allergic fungal sinusitis. Ann Allergy Asthma Immunol. 85:2000;90-97.
55. Andes D., Proctor B., Bush R.K., Pasic T.R. Report of successful prolonged antifungal therapy for refractory allergic fungal sinusitis. Clin Infect Dis. 31:2000;202-204.
56. Ponikau J.U., Sheris D.A., Kern E.B., Homburger H.A., Frigas E., Garffey T.A.et al. The diagnosis and incidence of allergic fungal sinusitis. Mayo Clin Proc. 74:1999;877-884.
57. Ferguson B.J. Definitions of fungal rhinosinusitis. Otolaryngol Clin North Am. 33:2000;227-235.
58. Ricchetti A., Landis B.N., Maffioli A., Giger R., Zeng C., Lacroix J.S. Effect of anti-fungal nasal lavage with amphotericin B on nasal polyposis. J Laryngol Otol. 116:2002;261-263.
59. Braun J.J., Alabert J.P., Michel F.B., Quiniou M., Rat C., Cougnard J.et al. Adjunct effect of loratadine in the treatment of acute sinusitis in patients with allergic rhinitis. Allergy. 52:1997;650-655.
60. Ulualp S.O., Sterman B.M., Toohill R.J. Antileukotriene therapy for the relief of sinus symptoms in aspirin triad disease. Ear Nose Throat J. 78:1999;604-606.
61. Ragab S., Parikh A., Darby Y.C., Scadding G.K. An open audit of montelukast, a leukotriene receptor antagonist, in nasal polyposis associated with asthma. Clin Exp Allergy. 31:2001;1385-1391.
62. Zeiss C.R., Lockey R.F. Refractory period to aspirin in a patient with aspirin-induced asthma. J Allergy Clin Immunol. 57:1976;440-448.
63. Berges-Gimeno M.P., Simon R.A., Stevenson D.D. Long-term treatment with aspirin desensitisation in asthmatic patients with aspirin-exacerbated respiratory disease. J Allergy Clin Immunol. 111:2003;180-186.
64. Stevenson D.D., Hankammer M.A., Mathison D.A., Christiansen S.C., Somon R.A. Aspirin desensitisation treatment of aspirin-sensitive patients with rhinosinusitis-asthma: long-term outcomes. J Allergy Clin Immunol. 98:1996;751-758.
65. Schapowal A.G., Simon H.U., Schmitz-Schumann M. Phenomenology, pathogenesis, diagnosis and treatment of aspirin sensitive rhinosinusitis. Acta Otorhinolaryngol Belg. 49:1995;235-250.
66. Gosepath J., Schafer D., Mann W.J. Analgetika-Intoleranz: Langzeitergebnisse bis zu 3 Jahren bei adaptiver Desaktivierung mit einer taglichen Erhaltungsdosis von 100mg aspirin. Laryngorhinootologie. 81:2002;732-738. in German.
67. Patriarca G., Nucera E., DiRienzo V., Schiavino D., Pellegrino S., Fais G. Nasal provocation test with lysine acetylsalicylate in aspirin sensitive patients. Ann Allergy. 67:1991;60-62.
68. Scadding G.K., Hassab M., Darby Y.C., Lund V.J., Freeman A. Intranasal lysine aspirin in recurrent nasal polyposis. Clin Otolaryngol. 20:1995;561-563.
69. Sousa A., Parikh A., Scadding G.K., Corrigan C., Lee T.H. Downregulation of cysteinyl leukotriene receptor by intranasal lysine aspirin in aspirin sensitive nasal polyposis. N Engl J Med. 347:2002;1524-1526.
70. Scadding G.K., Lund V.J., Darby Y.C., Navas-Romero J., Seymour N., Turner M.W. IgG Subclass levels in chronic rhinosinusitis. Rhinology. 32:1994;15-19.
71. Schlenter W.W., Blessing R., Heintz B. Zur konservativen Therapie der chronischen Sinusitis. Erfolge einer oralen Bakterienlysat-Therapie. Laryngorhinootologie. 68:1989;671-674. in German.
72. Zagar S., Lofler-Badzek D. Broncho-Vaxom in children with rhinosinusitis: a double blind clinical trial. ORL J Otorhinolaryngol Rel Spec. 50:1998;397-404.
73. Gomez-Barreto D., De La Torre C., Alvarez A., Faure A., Berber A. Safety and efficacy of OM-85-BV plus amoxicillin/clavulanate in the treatment of subacute sinusitis and the prevention of recurrent infections in children. Allergol Immunopathol (Madr). 26:1998;17-22.
74. Mathison D.A., Stevenson D.D., Simon R.A. Precipitating factors in asthma: aspirin, sulfites and other drugs and chemicals. Chest. 87(1 Suppl):1985;50S-54S.
75. Passali D., Mezzedimi C., Passali G.C., Bellussi L. Efficacy of inhalation form of furosemide to prevent postsurgical relapses of rhinosinusal polyposis. ORL J Otorhinolaryngol Relat Spec. 62:2000;307-310.
76. Lundberg J.O., Farkas-Szallasi T., Weitzberg E., Rinder J., Lidholm J., Anggaard A.et al. High nitric oxide production in human paranasal sinuses. Nat Med. 1:1995;370-373.
77. Lundberg J.O., Weitzberg E., Lundberg J.M., Alving K. Nitric oxide in exhaled air. Eur Respir J. 9:1996;2671-2680.
78. Colantonio L., Brouillette L., Parikh A., Scadding G.K. Paradoxical low nasal nitric oxide in nasal polyposis. Clin Exp Allergy. 32:2002;698-701.
79. Weitzberg E., Lundberg J.O. Humming greatly increases nasal nitric oxide. Am J Respir Crit Care Med. 166:2002;144-145.
80. Wodehouse T., Kharitonov S.A., Mackay I.S., Barnes P.J., Wilson R., Cole P.J. Nasal nitric oxide measurements for the screening of primary ciliary dyskinesia. Eur Respir J. 21:2003;43-47.
81. Wodehouse T. [PhD thesis]. 2002;University College, London.
82. Loukides S., Kharitonov S., Wodehouse T., Cole P.J. Effect of arginine on mucociliary function in primary ciliary dyskinesia. Lancet. 352:1998;371-372.
83. Stegeman C.A., Tervaert J.W., de Jong P.E., Kallenberg C.G. Trimethoprim-sulphamethoxazole (co-trimoxazole) for the prevention of relapses of Wegener's granulomatosis. Dutch Co-trimoxazole Wegener Study Group. N Engl J Med. 335:1996;16-19.
84. Clement P.A., Bluestone C.D., Gordts F., Lusk R.P., Otten F.W., Goossens H.et al. Management of rhinosinusitis in children. Int J Pediatr Otorhinolaryngol. 49:1999;S95-S100.
85. Jones N.S. Acute and chronic sinusitis in children. Curr Opin Pulm Med. 6:2000;221-225.